Signaling amplitude molds the Ras mutation tropism of urethane
Abstract
RAS genes are commonly mutated in cancers yet despite many possible mutations, cancers have a tropism towards a specific subset. As driver mutations, these patterns ostensibly originate from normal cells. High oncogenic RAS activity causes oncogenic stress and different oncogenic mutations can impart different levels of activity. Here we show that changing rare codons to common in the murine Kras gene to increase translation shifts tumors induced by the carcinogen urethane from arising from canonical Q61 to biochemically less active G12 Kras driver mutations, despite the carcinogen still being biased towards generating Q61 mutations. Loss of p53 to blunt oncogenic stress partially reversed this effect, restoring Q61 mutations. Finally, transcriptional analysis revealed similar signaling amongst tumors driven by different mutations and Kras alleles. These finding suggest that the RAS mutation tropism of urethane is largely product of selection in normal cells for mutations promoting proliferation without causing oncogenic stress. Impact statementThe bias towards specific Kras driver mutations during urethane carcinogenesis appears to arise predominantly from the selection of a narrow window of oncogenic signaling in normal cells.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RAS mutation patterns arise from tissue-specific responses to distinct oncogenic signaling
O. Erdogan, N. L. K. Pershing, … C. Counter·bioRxiv·Dec 10, 2021
- Hyper-mutational processes provide a head-start for weak cancer drivers: explaining atypical KRAS variants
Michael D. Nicholson, Ian P.M. Tomlinson·bioRxiv·Jan 29, 2025
- p53 dosage impedes KrasG12D- and KrasQ61R-mediated tumorigenesis
O. Le Roux, J. I. Everitt, C. M. Counter·bioRxiv·Sep 17, 2023
- Functional differences drive the selection of NRAS mutants in melanoma
B. M. Murphy, T. J. Weiss, … C. E. Burd·bioRxiv·Jan 15, 2021
- Ras protein abundance correlates with Ras isoform mutation patterns in cancer.
F. E. Hood, Y. M. Sahraoui, … I. A. Prior·bioRxiv·Nov 4, 2021
- An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants
M. P. Zafra, D. Alonso-Curbelo, … L. E. Dow·bioRxiv·Nov 20, 2019